Seminoma patients treated at a minor oncological department during 1986-2010: treatment and outcome

To present results for patients with seminoma treated at our University Clinic. All men treated for seminoma in 1986-2010 at the Department of Oncology, University Hospital of North Norway were included (n=232). Treatment was standardized from 2000 as the Swedish and Norwegian Testicular Cancer Proj...

Full description

Saved in:
Bibliographic Details
Published in:Anticancer research 2014-08, Vol.34 (8), p.4253-4260
Main Authors: Haugnes, Hege S, Solhaug, Øivind, Stenberg, Johannes, Hjelle, Line V, Bremnes, Roy M
Format: Article
Language:English
Subjects:
Adult
Aged
Aged, 80 and over
Humans
Male
Middle Aged
Neoplasm Staging
Radiotherapy, Adjuvant
Seminoma - mortality
Seminoma - pathology
Seminoma - radiotherapy
Testicular Neoplasms - mortality
Testicular Neoplasms - pathology
Testicular Neoplasms - radiotherapy
Time Factors
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To present results for patients with seminoma treated at our University Clinic. All men treated for seminoma in 1986-2010 at the Department of Oncology, University Hospital of North Norway were included (n=232). Treatment was standardized from 2000 as the Swedish and Norwegian Testicular Cancer Project (SWENOTECA) published their first standardised seminoma treatment program (SWENOTECA V). The percentage of patients administered adjuvant radiotherapy (RT) for clinical stage (CS) I decreased gradually from the late 1990s and was abandoned in 2005. Surveillance was the most common management strategy for CS I after 2000. Overall, disease in 1.9% and 11% of patients relapsed after adjuvant RT and surveillance, respectively. There were no relapses after treatment for metastatic disease. Cancer-specific survival was 100%, and overall survival 95% for the total group. The treatment outcome at our University Clinic is excellent with 100% cancer-specific survival, and is essentially a result of the bi-national SWENOTECA network.
ISSN:1791-7530